CDT Equity CDT
NASDAQ CDT
$2.86 -0.04 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

CDT Equity (CDT) Liabilities and Shareholders Equity (2021 - 2026)

CDT Equity's (CDT) quarterly Liabilities and Shareholders Equity came in at $127.1 million in Q1 2026, up 8372.47% YoY from $1.5 million in Q1 2025, and up 2149.33% on a QoQ basis from $5.6 million in Q4 2025.

CDT Equity (CDT) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

CDT Equity (CDT) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $127.1 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 8372.47% year-over-year to $127.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $142.8 million (up 1090.8% YoY) and the FY2025 annual result came in at $5.6 million, up 34.75% from the prior year.
  • Liabilities and Shareholders Equity improved to $127.1 million in Q1 2026, from $5.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $136.9 million in Q3 2022 to a low of $5000.0 in Q4 2022.
  • A 5-year average of $34.7 million and a median of $4.9 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • The widest YoY moves for Liabilities and Shareholders Equity: up 144380.0% in 2023, down 99.63% in 2023.
  • Tracing CDT's Liabilities and Shareholders Equity over 5 years: stood at $5000.0 in 2022, then jumped by 144380.0% to $7.2 million in 2023, then tumbled by 41.96% to $4.2 million in 2024, then jumped by 34.75% to $5.6 million in 2025, then surged by 2149.33% to $127.1 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $127.1 million (Q1 2026), $5.6 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 10.96 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 9.18 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.56 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.60 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.10 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 CDT Equity 1.55 Mn 1.55 Mn - 126.71 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 126.71 Mn
Mar 31, 2026 127.09 Mn
Dec 31, 2025 5.65 Mn
Sep 30, 2025 8.55 Mn
Jun 30, 2025 1.50 Mn
Mar 31, 2025 1.50 Mn
Dec 31, 2024 4.19 Mn
Sep 30, 2024 2.99 Mn
Jun 30, 2024 3.31 Mn
Mar 31, 2024 4.92 Mn
Dec 31, 2023 7.22 Mn
Sep 30, 2023 12.02 Mn
Jun 30, 2023 900,000.00
Mar 31, 2023 506,000.00
Dec 31, 2022 5,000.00
Sep 30, 2022 136.85 Mn
Jun 30, 2022 136.47 Mn
Mar 31, 2022 136.53 Mn
Dec 31, 2021 213,125.00